Forum Topics CUV CUV Clinuvel Pharmaceuticals Ltd General Discussion
knowlesy
Added 6 years ago

I must be missing something key and I'm not sure what, all the short sellers and positive reports I'm left to wonder the dropping price;

On 31 July 2020, CLINUVEL disclosed its quarterly cash flow report along with the activity report for the fourth quarter (ended 30 June 2020).

  • CLINUVEL had cash receipts worth approximately A$10.40 million for the June quarter.
  • The net cash flow in the June quarter reported at nearly A$7.17 million.
  • Cash and cash equivalents climbed by 7% over the quarter.
  • The Company expanded worldwide for supporting the development and continues to expand SCENESSE® supply in Europe.
  • CUV disclosed that first US patients treated with SCENESSE® from April.

I only ask as I am a holder of CUV and looking to pick more up on the way down but I'm left to wonder as to the why of the countinued decline and feel like I'm missing a key piece of information.

2